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Abstract
Introduction:  Serious injury to the optic nerve is an uncommon entity but may result in
permanent visual disability. Isolated trauma of the optic nerve is usually associated with blunt skull
trauma involving fractures of both skull and optic canal, but may also occur from blunt ocular
trauma.
Case presentation: We report a woman who developed isolated unilateral optic nerve edema
with corresponding visual deficits after a rear-end collision accident. She was treated with
corticosteroids and had a favourable outcome.
Conclusion: The approach described here was successful in this case but the current body of
evidence still lacks a validated approach to the management of traumatic optic neuropathy and each
case needs to be individually assessed.
Introduction
Serious injury to the optic nerve is an uncommon entity
but may result in permanent visual disability [1]. Interna-
tional rates vary according to the country with rates
depending on the occurrence of causative events, for
example non-fatal motor vehicle accidents and aggravated
assaults. In the United States, traumatic optic neuropathy
occurs in 0.5–5% of patients with closed head injuries and
in 2.5% of those with midfacial fractures [2]. Data from
Germany indicates impairment or loss of vision due to
optic nerve injury occurs in approximately 10% of
patients with craniofacial fractures [3]. Kallela et al.[4]
analyzed clinical and computerized tomography findings
from 10 patients with post-traumatic optic neuropathy
after maxillofacial blunt trauma. In their review the
number of blind eyes was 14 and all patients suffered
from midfacial fractures. Isolated trauma of the optic
nerve is usually associated with blunt skull trauma involv-
ing fractures of both skull and optical canal, but may also
occur from blunt ocular trauma [5]. We report on a
woman who developed isolated unilateral optic nerve
edema with corresponding visual deficits after a rear-end
collision accident. She was treated with corticosteroids
and had a favourable outcome.
Case presentation
A 45-year-old female was admitted to the emergency
department (ED) following a rear-end collision accident.
At the scene the patient was awake but somewhat somno-
lent. Her circulatory function was compensated with a
blood pressure (BP) of 150/80 mmHg and she com-
plained of back pain. Following initial assessment the
patient was transferred via helicopter to our level 1 trauma
centre for further evaluation and treatment. Upon arrival
in our trauma bay the clinical picture was unchanged.
Detailed clinical assessment including laboratory tests,
Published: 18 February 2008
Journal of Medical Case Reports 2008, 2:50 doi:10.1186/1752-1947-2-50
Received: 30 July 2007
Accepted: 18 February 2008
This article is available from: http://www.jmedicalcasereports.com/content/2/1/50
© 2008 Maegele; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Journal of Medical Case Reports 2008, 2:50 http://www.jmedicalcasereports.com/content/2/1/50
Page 2 of 5
(page number not for citation purposes)
ultrasound, radiology and computed tomography (CT)
was negative and the patient was transferred to our inten-
sive care unit (ICU) for observation. Within one day her
cognitive function had returned to normal and the patient
was transferred to one of our normal wards. On day 2 fol-
lowing the trauma the patient complained of blurred
vision. Ophthalmology assessment revealed a visual field
loss affecting the right lower quadrant on confrontation
field testing. Clinical eye examination further revealed a
visual acuity for the right eye of 0.5 decimal (LogMAR
0.30, Snellen ratio 20/40) and for the left eye of 0.8 deci-
mal (LogMAR 0.1, Snellen ratio 20/25). Pupil testing indi-
cated an afferent defect of the right eye. There was no
history of eye disease prior to the accident. Imaging stud-
ies, including magnetic resonance imaging (MRI) of the
orbit, showed an isolated unilateral distension of the right
optic nerve with edematous soaking of the adjacent retro-
orbital fat (Figure 1). There was no fracture of the skull or
of the optic canal and no intracranial pathology was
noted. High-dose corticosteroids were administered for
three consecutive days and then reduced, i.e. prednisone
250 mg IV for three days, reduced to 100 mg IV and
stopped. The patient's symptoms responded quickly to
this approach. Repeated eye examination after one week
showed normal testing results for pupillary function and
confrontation fields, and visual acuities returned to 1.0
decimal on both eyes (LogMAR 0.00, Snellen ratio 20/
20).
Discussion
The intra-orbital segment of the optic nerve is usually
spared from injury due to its laxity and buffering by the
surrounding fat and extraocular muscles. The intracranial
segment is protected by the surrounding brain and bone
as well as the fact that shearing forces are usually absorbed
by the intracanalicular segment thus not reaching the
intracranial segment. Some investigational studies have
shown that blows to the malar and frontal areas are trans-
mitted mostly to the optic foramen[2]. These forces may
cause compression, shearing, contusion and stretching
injuries to the optic nerve, even in the absence of a frac-
ture. Furthermore, the sheath of the optic nerve is firmly
attached to the optic canal, and the canal itself is a closed
space, not flexible to any edema or hemorrhage [2,6].
The mechanisms of trauma frequently associated with
traumatic optic neuropathy comprise motor vehicle acci-
dents, as shown in our case, but also bicycle accidents,
falls, assaults, penetrations, recreational sports injuries, or
surgical intervention in the case of orbitofacial fracture
repair.
The pathophysiology of post-traumatic optic neuropathy
is poorly understood. Most commonly, traumatic optic
neuropathy occurs as an indirect event during or shortly
after blunt trauma to the superior or lateral orbital rim,
the frontal area, or the cranium. Trauma-associated com-
pression forces are transmitted through the orbital bones
to the orbital apex and the optic canal. Contusion of the
intracanalicular optic nerve axons and pial microvascula-
ture leads to local optic nerve ischemia and edema. Ede-
matous ischemic axons result in further neural
compression, induce a postive feedback loop and may
thus trigger the development of an intracanalicular com-
partment syndrome with further necrosis and infarc-
tion[6]. Vascular insufficiency may also contribute to the
development of traumatic optic neuropathy. During the
initial phase, hemorrhage into the nerve, or into any layer
of its sheath, laceration and contusion necrosis may occur
as a result of the shearing forces.
Secondary damage may not be present initially but may
occur later resulting from compromised blood supply to
the optic nerve, e.g. following chronic edema, hemor-
rhage or angiospasm [5]. Our patient had been involved
in a rear-end collision accident with a combination of a
significant deceleration momentum obviously inducing a
sudden and forceful shear on the optic nerve, and a phys-
ical impact to the head which hit against the window of
the vehicle. Similar but more dramatic scenarios have
been described indicating that refractory evulsion of the
optic nerve, with similar morphological features as pre-
sented here, but also poorer clinical prognosis leading to
blindness may occur [7].
Sudden and forceful rotational movements of the eye can
tear off the optic nerve at its globe entry level. Post-trau-
matic loss of vision may also manifest up to two months
after the initial impact leading to delayed diagnosis and
unresponsiveness to treatment [8].
Clinical assessment should include testing of visual acu-
ity, extraocular muscle motility and papillary reactivity,
visual field assessment and direct/indirect ophthalmos-
copy. Detailed gonioscopy will rule out potential con-
founding anterior segment pathologies. The pertinent
findings upon clinical examination are impaired visual
function and an afferent pupillary defect on the swinging
flashlight test, both with an eye that appears normal [6].
The patient reported here displayed a substantial decrease
in visual acuity together with a visual field loss to the right
lower quadrant upon confrontation field testing. Visual
evoked potentials (VEPs) to flash stimulation and the
electroretinogram (ERG) might be supportive in unre-
sponsive patients in the immediate aftermath of the trau-
matic event [3,9]. Altenmüller et al.[3] reported good
correlation of initial VEPs with the visual acuity and visual
fields examined after patients had regained conscious-
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The role of neuroimaging remains controversial and prac-
tice varies between institutions. While some colleagues
request computed tomography (CT) and/or magnetic res-
onance imaging (MRI) for diagnosis, others limit these to
patients with progressive visual deterioration or if thera-
peutic interventions are being considered. The clinical
value of neuroimaging in traumatic optic neuropathy is
further debatable since there is no consistent correlation
between the finding of an optic canal fracture, the severity
of visual loss and the prognosis for visual recovery.
Recently ultrasonography has been advocated to screen
and detect abnormalities in optic nerve diameter in
patients who have experienced head trauma that could
Magnetic resonance tomography shows isolated unilateral distension of the right optic nerve (arrows in panels a and b) Figure 1
Magnetic resonance tomography shows isolated unilateral distension of the right optic nerve (arrows in panels 
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involve the optic nerve [8,10], including its use in bedside
emergency department conditions [11].
Currently, there is no validated approach to the manage-
ment of traumatic optic neuropathy. The International
Optic Nerve Trauma Study [12] was initiated to compare
the visual outcomes of patients observed without treat-
ment with those of patients treated with corticosteroids
and of patients treated with optic canal decompression
surgery. This multicenter, comparative, interventional but
non-randomized trial comprised 133 patients with trau-
matic optic neuropathy from 16 countries. Treatment
decisions were according to the investigators' customary
practice and no specific protocols for corticosteroid treat-
ment or surgical technique were followed. The results
showed that visual acuity improved in32% of patients
treated with surgery, in52% of patients treated with corti-
costeroids, and in 57% of untreated patients. Thus, there
was no clear benefit observed for either corticosteroid
therapy or optic canal decompression. The results further
showed that neither the dosage or timing of corticosteroid
treatment nor the timing of optic canal decompression
were associated with an increased probability of improved
visual acuity. The authors concluded that neither corticos-
teroid therapy nor optic canal decompression should be
considered the standard of care for patients with traumatic
optic neuropathy and that therapeutic decisions should
be made on an individual patient basis. In the present
case, the patient's symptoms quickly responded to corti-
costeroid therapy but considering the results from the
International Optic Nerve Trauma Study, this patient may
have improved without any specific therapy whatsoever as
well.
The rationale for intravenous corticosteroids for the treat-
ment of traumatic optic neuropathy was derived from the
results of the National Acute Spinal Cord Injury Study
2(NASCIS 2). The NASCIS 2 was a multicenter clinical
trial that evaluated patients with acute spinal cord injury
treated with placebo, methylprednisolone, or naloxone.
Pharmacologically, corticosteroids are considered to
reduce microvascular spasm and soft tissue edema via sta-
bilization of the microvascular circulation and calcium
homeostasis, thereby enhancing bloodflow and reducing
cell death. The study showed that methylprednisolone
started within 8 hours of injury was associated with a sig-
nificant improvement in both motor and sensory func-
tion compared to patients treated with a placebo.
Although widely accepted, the question whether corticos-
teroids are of similar effect in the treatment of traumatic
optic neuropathy is unproven.
The majority of case reports and series with corticosteroids
in traumatic optic neuropathy are retrospective, non-con-
secutive, non-randomized, and uncontrolled. Meanwhile,
several non-clinical studies have questioned the therapeu-
tic benefit associated with corticosteroids in acute trau-
matic optic neuropathy [13,14]. The results from the
CRASH-trial indicated an even higher risk of mortality in
patients with head injury treated with high-dose corticos-
teroids. The author acknowledges that if a clinician
chooses to administer corticosteroids that have no proven
benefit and the patient dies, a medicolegal issue may arise
because of the results from the CRASH-trial.
One may speculate that the pure white matter optic nerve
is not pharmacologically affected in the same manner as
the mixed white and gray matter spinal cord.
Surgical optic nerve decompression has similarly been
advocated to improve visual prognosis in traumatic optic
neuropathy. Recently, YuWai Man and Griffiths [15]
assessed the effects and safety of surgical interventions in
the management of traumatic optic neuropathy. Based
upon only small and retrospective case series, and the
wide range of surgical interventions used, they encoun-
tered considerable difficulties in comparing the body of
evidence available. Given the relatively high rate of spon-
taneous visual recovery they concluded that there is no
evidence that surgical decompression of the optic nerve
provides any additional benefit [15]. However, in selected
cases in which orbital bone fragments or foreign bodies
impinge on, but do not transect the optic nerve, surgical
intervention may be indicated. In any case, one should be
aware of the fact that surgical intervention carries a defi-
nite risk of complications such as collateral damage to
structures of the orbital apex as well as other intracranial
structures, or iatrogenic direct and indirect optic nerve
damage, the latter via disruption of the pia, as well as post-
operative cerebrospinal fluid leaks and meningitis. Simi-
lar to corticosteroids, the use of surgery in traumatic optic
neuropathy remains controversial and each case needs to
be individually assessed.
Conclusion
The coincidence with the traumatic event, the absence of
any eye pathology prior to the traumatic event and the
exclusion of any alternative cause for an optic nerve swell-
ing prompted the diagnosis in this patient of a post-trau-
matic unilateral optic nerve contusion with
corresponding visual deficit which quickly responded to
steroid therapy. This approach was successful in the case
reported here but the current body of evidence still lacks a
validated approach to the management of traumatic optic
neuropathy and each case needs to be individually
assessed. There is a need for a large, prospective, rand-
omized controlled trial to assess the different therapeutic
approaches in traumatic optic neuropathy but such a trial
may be challenging given the low frequency of the condi-
tion and the difficulties inherent in randomizing patients.Publish with BioMed Central    and   every 
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Editor's note:
"Peer review has identified that the CRASH trial suggests that giving steroids in a 
patient with head trauma increases mortality. This case report suggests that giving 
steroids is helpful. In the final published version of this manuscript the author 
acknowledges that if a clinician chooses to administer corticosteroids, that have 
no proven benefit, and the patient dies, a medicolegal issue may arise because of 
the results from the CRASH-trial. It should be noted that one peer reviewer stated 
that it is not reasonable to give steroids to patients with traumatic optic neuropa-
thy anymore because of the natural history is the same as without steroids and 
the risk of dying can be increased by giving steroids. This is an area of clinical con-
troversy and we urge readers to remember that this is only a single case report 
and that clinical decision making should always be based on the best available evi-
dence."
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